MindWalk Holdings (HYFT) EBITDA Margin Growth (3y) (2023 - 2026)
MindWalk Holdings (HYFT) EBITDA Margin Growth (3y) (2023 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
MindWalk Holdings |
166.20 Mn |
156.06 Mn |
1.78 |
-1,890.00 |
| Date | Value |
|---|
| Jan 31, 2026 |
-1,890.00 |
| Oct 31, 2025 |
7.58 Bn |
| Jul 31, 2025 |
-10,985.00 |
| Apr 30, 2025 |
-2.43 Bn |
| Jan 31, 2025 |
8.16 Mn |
| Oct 31, 2024 |
20,733.00 |
| Jul 31, 2024 |
14,071,977.36 Bn |
| Apr 30, 2024 |
-28,218.00 |
| Jan 31, 2024 |
7,863.00 |
| Oct 31, 2023 |
6,185.00 |
